Laboratory Evaluation of FR10024, a New Cephalosporin Derivative

FR10024 is a broad-spectrum antibiotic. The in vitro antibacterial activity of FR10024 against clinical isolates of Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis is greater than that of any of the cephalosporins developed to date. Indole-positive Proteus, Ente...

Celý popis

Podrobná bibliografie

Vydáno v:	Antimicrob Agents Chemother
Hlavní autoři:	Nishida, Minoru, Murakawa, Takeo, Kamimura, Toshiaki, Okada, Naohiko, Fukada, Shigemi, Sakamoto, Hiroshi, Nakamoto, Shoji, Yokota, Yoshiko, Kono, Yoko
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1977
Témata:	Pharmacology and Therapeutics
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC351918/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/836014/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.11.1.51
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!